Preparing Self-Funded Plans for the Game-Changing Impact of Biosimilars

Featuring PCM’s Chief Pharmacist, Dr. David Merritt PharmD, RPh, we will take a closer look at how biosimilar adoption will affect plan and patient costs, breaking down spend on an actual group and discussing ways to increase adoption through physician and patient education.